Annual CFO
-$7.29 M
+$7.94 M+52.12%
December 31, 2023
Summary
- As of February 7, 2025, OGEN annual cash flow from operations is -$7.29 million, with the most recent change of +$7.94 million (+52.12%) on December 31, 2023.
- During the last 3 years, OGEN annual CFO has risen by +$9.66 million (+56.99%).
- OGEN annual CFO is now -498.15% below its all-time high of -$1.22 million, reached on December 31, 2003.
Performance
OGEN Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$1.97 M
-$425.80 K-27.57%
September 30, 2024
Summary
- As of February 7, 2025, OGEN quarterly cash flow from operations is -$1.97 million, with the most recent change of -$425.80 thousand (-27.57%) on September 30, 2024.
- Over the past year, OGEN quarterly CFO has dropped by -$867.80 thousand (-78.71%).
- OGEN quarterly CFO is now -1866.37% below its all-time high of -$100.20 thousand, reached on March 31, 2003.
Performance
OGEN Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$7.68 M
-$467.30 K-6.48%
September 30, 2024
Summary
- As of February 7, 2025, OGEN TTM cash flow from operations is -$7.68 million, with the most recent change of -$467.30 thousand (-6.48%) on September 30, 2024.
- Over the past year, OGEN TTM CFO has dropped by -$390.70 thousand (-5.36%).
- OGEN TTM CFO is now -7566.17% below its all-time high of -$100.20 thousand, reached on March 31, 2003.
Performance
OGEN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
OGEN Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +52.1% | -78.7% | -5.4% |
| 3 y3 years | +57.0% | -78.7% | -5.4% |
| 5 y5 years | +19.7% | -78.7% | -5.4% |
OGEN Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +52.1% | -78.7% | +65.0% | -6.5% | +52.2% |
| 5 y | 5-year | at high | +57.0% | -78.7% | +65.0% | -6.5% | +56.0% |
| alltime | all time | -498.1% | +57.0% | -1866.4% | +65.0% | -7566.2% | +56.0% |
Oragenics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.97 M(+27.6%) | -$7.68 M(+6.5%) |
| Jun 2024 | - | -$1.54 M(-49.6%) | -$7.21 M(-12.5%) |
| Mar 2024 | - | -$3.06 M(+177.9%) | -$8.25 M(+13.1%) |
| Dec 2023 | -$7.29 M(-52.1%) | -$1.10 M(-26.6%) | -$7.29 M(-15.4%) |
| Sep 2023 | - | -$1.50 M(-41.7%) | -$8.62 M(-20.9%) |
| Jun 2023 | - | -$2.58 M(+22.2%) | -$10.89 M(-6.9%) |
| Mar 2023 | - | -$2.11 M(-13.3%) | -$11.70 M(-23.2%) |
| Dec 2022 | -$15.23 M(+13.1%) | -$2.43 M(-35.6%) | -$15.23 M(-0.3%) |
| Sep 2022 | - | -$3.78 M(+11.6%) | -$15.28 M(-5.0%) |
| Jun 2022 | - | -$3.38 M(-40.0%) | -$16.08 M(+8.8%) |
| Mar 2022 | - | -$5.64 M(+126.9%) | -$14.78 M(+9.7%) |
| Dec 2021 | -$13.47 M(-20.5%) | -$2.48 M(-45.7%) | -$13.47 M(-7.8%) |
| Sep 2021 | - | -$4.58 M(+120.4%) | -$14.62 M(-0.6%) |
| Jun 2021 | - | -$2.08 M(-52.0%) | -$14.70 M(-15.8%) |
| Mar 2021 | - | -$4.33 M(+19.2%) | -$17.46 M(+3.0%) |
| Dec 2020 | -$16.95 M(+30.3%) | -$3.63 M(-22.2%) | -$16.95 M(-1.8%) |
| Sep 2020 | - | -$4.67 M(-3.5%) | -$17.26 M(+8.1%) |
| Jun 2020 | - | -$4.83 M(+26.4%) | -$15.97 M(+9.2%) |
| Mar 2020 | - | -$3.82 M(-2.9%) | -$14.63 M(+12.4%) |
| Dec 2019 | -$13.01 M(+43.3%) | -$3.94 M(+16.5%) | -$13.01 M(+8.0%) |
| Sep 2019 | - | -$3.38 M(-3.2%) | -$12.05 M(+8.3%) |
| Jun 2019 | - | -$3.49 M(+57.8%) | -$11.13 M(+12.2%) |
| Mar 2019 | - | -$2.21 M(-25.8%) | -$9.92 M(+9.3%) |
| Dec 2018 | -$9.08 M(+42.7%) | -$2.98 M(+21.3%) | -$9.08 M(+21.7%) |
| Sep 2018 | - | -$2.45 M(+7.6%) | -$7.46 M(+17.6%) |
| Jun 2018 | - | -$2.28 M(+66.9%) | -$6.35 M(+8.8%) |
| Mar 2018 | - | -$1.37 M(+0.6%) | -$5.83 M(-8.4%) |
| Dec 2017 | -$6.36 M(-10.1%) | -$1.36 M(+1.4%) | -$6.36 M(-8.7%) |
| Sep 2017 | - | -$1.34 M(-24.1%) | -$6.97 M(-3.2%) |
| Jun 2017 | - | -$1.76 M(-7.1%) | -$7.20 M(-2.1%) |
| Mar 2017 | - | -$1.90 M(-3.2%) | -$7.36 M(+4.0%) |
| Dec 2016 | -$7.08 M(+36.3%) | -$1.96 M(+25.0%) | -$7.08 M(+4.5%) |
| Sep 2016 | - | -$1.57 M(-18.2%) | -$6.77 M(+4.2%) |
| Jun 2016 | - | -$1.92 M(+18.5%) | -$6.50 M(+17.7%) |
| Mar 2016 | - | -$1.62 M(-2.5%) | -$5.52 M(+6.4%) |
| Dec 2015 | -$5.19 M(-6.6%) | -$1.66 M(+28.2%) | -$5.19 M(+10.2%) |
| Sep 2015 | - | -$1.30 M(+37.3%) | -$4.71 M(+4.4%) |
| Jun 2015 | - | -$943.70 K(-26.8%) | -$4.51 M(-14.3%) |
| Mar 2015 | - | -$1.29 M(+9.1%) | -$5.26 M(-5.3%) |
| Dec 2014 | -$5.56 M(-17.8%) | -$1.18 M(+7.5%) | -$5.56 M(-0.7%) |
| Sep 2014 | - | -$1.10 M(-35.3%) | -$5.60 M(-13.4%) |
| Jun 2014 | - | -$1.70 M(+7.1%) | -$6.46 M(-4.5%) |
| Mar 2014 | - | -$1.58 M(+29.9%) | -$6.77 M(+0.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | -$6.76 M(+29.8%) | -$1.22 M(-37.9%) | -$6.76 M(-7.2%) |
| Sep 2013 | - | -$1.96 M(-1.8%) | -$7.29 M(+12.1%) |
| Jun 2013 | - | -$2.00 M(+26.5%) | -$6.50 M(+15.1%) |
| Mar 2013 | - | -$1.58 M(-9.2%) | -$5.65 M(+8.4%) |
| Dec 2012 | -$5.21 M(-5.1%) | -$1.74 M(+47.8%) | -$5.21 M(+7.2%) |
| Sep 2012 | - | -$1.18 M(+2.4%) | -$4.86 M(-6.5%) |
| Jun 2012 | - | -$1.15 M(+0.6%) | -$5.20 M(-5.6%) |
| Mar 2012 | - | -$1.14 M(-17.8%) | -$5.51 M(+0.4%) |
| Dec 2011 | -$5.49 M(-14.8%) | -$1.39 M(-8.4%) | -$5.49 M(-6.5%) |
| Sep 2011 | - | -$1.52 M(+3.9%) | -$5.88 M(+2.1%) |
| Jun 2011 | - | -$1.46 M(+30.0%) | -$5.75 M(+1.7%) |
| Mar 2011 | - | -$1.12 M(-36.6%) | -$5.66 M(-12.3%) |
| Dec 2010 | -$6.45 M(+11.2%) | -$1.77 M(+27.0%) | -$6.45 M(+6.4%) |
| Sep 2010 | - | -$1.40 M(+2.1%) | -$6.06 M(-14.4%) |
| Jun 2010 | - | -$1.37 M(-28.6%) | -$7.08 M(+7.5%) |
| Mar 2010 | - | -$1.91 M(+38.1%) | -$6.59 M(+13.6%) |
| Dec 2009 | -$5.80 M(+51.2%) | -$1.39 M(-42.5%) | -$5.80 M(-2.0%) |
| Sep 2009 | - | -$2.41 M(+175.3%) | -$5.92 M(+34.3%) |
| Jun 2009 | - | -$875.90 K(-22.2%) | -$4.41 M(-0.5%) |
| Mar 2009 | - | -$1.13 M(-25.1%) | -$4.43 M(+15.5%) |
| Dec 2008 | -$3.84 M(+100.4%) | -$1.50 M(+67.0%) | -$3.84 M(+37.7%) |
| Sep 2008 | - | -$900.20 K(+0.1%) | -$2.78 M(+19.0%) |
| Jun 2008 | - | -$899.40 K(+69.1%) | -$2.34 M(+15.0%) |
| Mar 2008 | - | -$531.90 K(+17.4%) | -$2.04 M(+6.3%) |
| Dec 2007 | -$1.91 M(-14.0%) | -$453.00 K(-0.7%) | -$1.91 M(-0.7%) |
| Sep 2007 | - | -$456.20 K(-23.2%) | -$1.93 M(+1.5%) |
| Jun 2007 | - | -$594.00 K(+44.7%) | -$1.90 M(+0.2%) |
| Mar 2007 | - | -$410.50 K(-12.1%) | -$1.90 M(-14.8%) |
| Dec 2006 | -$2.22 M(-35.2%) | -$467.20 K(+9.4%) | -$2.22 M(-2.9%) |
| Sep 2006 | - | -$427.10 K(-27.6%) | -$2.29 M(-11.3%) |
| Jun 2006 | - | -$590.20 K(-20.2%) | -$2.58 M(-10.7%) |
| Mar 2006 | - | -$740.00 K(+38.5%) | -$2.89 M(-15.8%) |
| Dec 2005 | -$3.43 M(+25.1%) | -$534.20 K(-25.7%) | -$3.43 M(-7.3%) |
| Sep 2005 | - | -$718.80 K(-20.0%) | -$3.71 M(+3.5%) |
| Jun 2005 | - | -$898.80 K(-29.9%) | -$3.58 M(+2.8%) |
| Mar 2005 | - | -$1.28 M(+59.3%) | -$3.48 M(+26.9%) |
| Dec 2004 | -$2.75 M(+125.2%) | -$805.40 K(+35.4%) | -$2.75 M(+15.4%) |
| Sep 2004 | - | -$595.00 K(-25.6%) | -$2.38 M(+10.5%) |
| Jun 2004 | - | -$799.60 K(+46.7%) | -$2.15 M(+29.3%) |
| Mar 2004 | - | -$545.10 K(+24.3%) | -$1.66 M(+36.5%) |
| Dec 2003 | -$1.22 M | -$438.50 K(+19.0%) | -$1.22 M(+56.2%) |
| Sep 2003 | - | -$368.60 K(+18.3%) | -$780.40 K(+89.5%) |
| Jun 2003 | - | -$311.60 K(+211.0%) | -$411.80 K(+311.0%) |
| Mar 2003 | - | -$100.20 K | -$100.20 K |
FAQ
- What is Oragenics annual cash flow from operations?
- What is the all time high annual CFO for Oragenics?
- What is Oragenics annual CFO year-on-year change?
- What is Oragenics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Oragenics?
- What is Oragenics quarterly CFO year-on-year change?
- What is Oragenics TTM cash flow from operations?
- What is the all time high TTM CFO for Oragenics?
- What is Oragenics TTM CFO year-on-year change?
What is Oragenics annual cash flow from operations?
The current annual CFO of OGEN is -$7.29 M
What is the all time high annual CFO for Oragenics?
Oragenics all-time high annual cash flow from operations is -$1.22 M
What is Oragenics annual CFO year-on-year change?
Over the past year, OGEN annual cash flow from operations has changed by +$7.94 M (+52.12%)
What is Oragenics quarterly cash flow from operations?
The current quarterly CFO of OGEN is -$1.97 M
What is the all time high quarterly CFO for Oragenics?
Oragenics all-time high quarterly cash flow from operations is -$100.20 K
What is Oragenics quarterly CFO year-on-year change?
Over the past year, OGEN quarterly cash flow from operations has changed by -$867.80 K (-78.71%)
What is Oragenics TTM cash flow from operations?
The current TTM CFO of OGEN is -$7.68 M
What is the all time high TTM CFO for Oragenics?
Oragenics all-time high TTM cash flow from operations is -$100.20 K
What is Oragenics TTM CFO year-on-year change?
Over the past year, OGEN TTM cash flow from operations has changed by -$390.70 K (-5.36%)